Global Private Equity Capital Is Transforming India's Hospital Sector, but Rising Medical Bills Are Triggering Concerns Over Affordability and Patient Access

India's healthcare sector has emerged as a major destination for global private equity capital, with investors betting heavily on rising demand for specialised medical treatment, hospital infrastructure and organised healthcare chains. Over the past five years, Blackstone, KKR, TPG, General Atlantic, Temasek and other global investors have invested around $10 billion in Indian hospital chains, according to data compiled by EY.

The influx of capital has helped hospitals expand capacity, acquire advanced medical technology and consolidate fragmented healthcare businesses. But the rapid financialisation of the sector is also generating a growing debate over the cost of treatment and who ultimately bears the burden of rising healthcare expenses.

The issue has increasingly brought hospitals, insurers, policymakers and investors into conflict, with patients caught in the middle.

Private Equity Sees a Large and Growing Healthcare Opportunity

India remains significantly under-served in terms of hospital infrastructure. The country has roughly 1.3 hospital beds per 1,000 people, considerably below the levels seen in many developed economies.

At the same time, demand for cancer treatment, cardiac care, organ-related procedures and other specialised medical services has been increasing as incomes rise, life expectancy improves and awareness of advanced healthcare grows.

The combination has created an attractive investment opportunity for private equity firms.

Hospitals require substantial upfront capital, but established facilities can generate recurring cash flows once occupancy and patient volumes increase. Investors have also seen opportunities to consolidate India's fragmented hospital market by acquiring standalone facilities and combining them into larger networks.

Government estimates in 2021 identified around 600 hospital projects requiring approximately $32 billion of investment, highlighting the scale of India's healthcare infrastructure gap.

Hospital Consolidation Accelerates

Private equity-backed consolidation has become an important feature of India's hospital industry.

Although PE-backed operators still account for less than 5 per cent of India's hospital beds, they have established a significant presence in high-margin specialties such as cardiac care, oncology and other tertiary-care services.

KKR's investment in Kerala-based Baby Memorial in 2024 is one example of how private capital is being used to expand hospital networks. The operator, which had around 1,000 beds when KKR invested, subsequently expanded through acquisitions and exceeded its pretax earnings target, according to people familiar with the business.

KKR has continued to expand its healthcare portfolio. Its agreement in August to acquire the Indian operations of Swedish hospital group Medicover for about $1.4 billion is expected to substantially increase its hospital-bed footprint in southern India.

The private equity firm has also previously backed Radiant Life Care and played a role in its combination with Max Healthcare Institute, creating one of India's major hospital platforms.

Strong Returns Make Healthcare More Attractive to Investors

India's increasingly mature capital markets have further strengthened the investment case.

Initial public offerings and secondary share sales provide private equity investors with clearer exit opportunities than were available in earlier years. Successful exits allow investors to recycle capital into new hospital acquisitions and expansion projects.

Temasek's investment in Manipal Health Enterprises is another example. The investor reportedly generated roughly a tenfold return on its 2017 investment following a partial stake sale during Manipal's public-market debut in July.

Such returns have reinforced the perception of Indian healthcare as a long-term growth opportunity for global institutional capital.

Hospital Revenues Expected to Keep Growing

The financial outlook for private hospitals remains strong.

Crisil expects private hospital revenue in India to grow by as much as 15 per cent in fiscal 2027, supported by higher patient volumes and an estimated increase of up to 7 per cent in average revenue per occupied bed.

For hospital operators and their investors, higher occupancy, expansion into specialised treatments and greater revenue per patient can significantly improve returns on capital.

However, the same factors are also intensifying concerns about affordability.

Rising Medical Inflation Raises Affordability Concerns

India's healthcare investment boom has coincided with rapidly increasing medical costs.

A parliamentary report has indicated that medical inflation has been running as high as 13 per cent annually. Treatment at private hospitals can cost five to 10 times more than comparable treatment in the public healthcare system, with particularly large differences reported in areas such as cancer care, cardiac treatment, kidney-related treatment and maternity services.

For middle-income households, the challenge is particularly acute.

People who do not qualify for government-supported healthcare schemes may also lack sufficient insurance coverage or savings to absorb unexpectedly large medical bills.

This has created concerns about a growing gap between access to advanced healthcare and the ability of patients to pay for it.

Hospitals and Insurers Clash Over Medical Bills

The conflict has increasingly shifted towards the relationship between hospitals and health insurers.

Insurers argue that some private hospitals inflate treatment costs or encourage patients towards expensive procedures. Hospitals, on the other hand, contend that insurance companies delay payments and reimburse treatments at rates that do not adequately reflect their operating costs.

The disagreement is particularly visible when hospitals introduce expensive technologies and advanced procedures.

Insurers are questioning whether every high-cost procedure provides sufficient additional clinical benefit to justify the expense, while hospital operators argue that newer technologies, implants and surgical techniques can improve patient outcomes.

Robotic Surgery Becomes a Flashpoint

Robotic-assisted procedures have emerged as one example of this debate.

According to industry representatives, some robotic procedures can cost significantly more than conventional surgery without necessarily providing a proportionate improvement in clinical outcomes.

Insurers therefore want evidence-based treatment protocols before agreeing to reimburse expensive procedures.

Hospitals, meanwhile, argue that technological advances can offer benefits that are difficult to capture through simple cost comparisons.

For patients, the disagreement can create uncertainty over what their insurance policy will actually cover.

Patients Bear the Impact of Coverage Disputes

The problem becomes particularly difficult when treatment decisions have already been made.

A patient's expectation may be that a health insurance policy will cover a procedure, only for the insurer to reject a specific component of the hospital bill.

In one case cited in the report, a Mumbai-based patient undergoing robot-assisted surgery expected her state-run insurance policy to cover the procedure. The insurer subsequently declined to reimburse the robotic component, leaving the patient to pay the difference herself.

Such disputes illustrate the growing complexity of healthcare financing, where hospitals, insurers and patients may have different interpretations of what constitutes medically necessary and reimbursable treatment.

Regulators Face a Difficult Balancing Act

The growing debate has attracted increasing attention from policymakers.

A parliamentary committee in August raised concerns about what it described as an unchecked influx of foreign capital into Indian healthcare. It recommended reconsidering aspects of foreign investment policy, examining price caps and exploring the creation of a dedicated regulator for hospitals.

The Insurance Regulatory and Development Authority of India has also introduced measures related to cashless treatment and standardised authorisation procedures in an attempt to reduce friction between hospitals and insurers.

However, regulation alone may not resolve the underlying economics of healthcare.

The experience of countries such as the United States shows that controlling medical costs while maintaining investment, innovation and capacity is a difficult policy challenge.

Investors Warn Against Excessive Price Regulation

Global investors have also pushed back against proposals for greater government intervention in healthcare pricing.

Jean Eric Salata, chair of EQT Group, has argued that extensive pricing regulation could undermine India's investment environment and discourage further foreign capital.

The argument from investors is that private capital is necessary to build hospitals, purchase advanced equipment, expand specialist capacity and improve healthcare infrastructure. Excessive regulation, they contend, could reduce the incentive to commit capital to a sector that already requires substantial upfront investment.

Policymakers therefore face a difficult balancing act: encouraging investment while ensuring that the resulting healthcare capacity remains accessible and affordable.

India's "Missing Middle" Faces the Biggest Risk

The affordability debate is particularly important for India's so-called missing middle — households that may not qualify for government healthcare support but also lack the financial capacity to absorb rapidly rising private medical expenses.

For these families, health insurance is increasingly becoming essential. However, if premiums rise alongside medical inflation while insurers restrict coverage for expensive procedures, the protection offered by insurance could become less effective.

This creates a potential cycle in which rising hospital costs increase insurance expenses, higher premiums reduce affordability and patients are left with larger out-of-pocket payments.

Healthcare Growth vs Affordability

India's hospital industry is entering a crucial phase.

On one side, the country needs significant investment to increase hospital capacity, expand specialist treatment and bring advanced medical technology to more patients. Private equity capital can play an important role in meeting that requirement.

On the other side, healthcare cannot become increasingly expensive without raising questions about access.

The challenge is therefore not simply about how much capital enters the sector, but how efficiently that capital translates into additional capacity, better outcomes and affordable treatment.

What Lies Ahead for India's Healthcare Sector?

The next phase of India's healthcare growth is likely to involve greater scrutiny of hospital pricing, insurance coverage, treatment protocols and the returns generated by private capital.

Investors are likely to remain attracted to the sector because of favourable long-term demographics, low hospital-bed availability, rising healthcare awareness and increasing demand for specialised treatment.

However, regulatory developments and the relationship between insurers and hospitals could become increasingly important investment considerations.

For hospital operators, maintaining profitability while demonstrating value to patients and insurers will be critical. For insurers, controlling claims costs without restricting necessary treatment will remain equally important.

Market Outlook

India's healthcare sector presents a powerful long-term investment opportunity, but the next stage of growth will increasingly depend on balancing capital returns with patient affordability.

The roughly $10 billion invested by global private equity firms over the past five years demonstrates the confidence international investors have in India's healthcare demand story. Hospital consolidation, rising occupancy, specialised treatments and advanced technology can continue to support revenue growth.

However, rapidly rising medical inflation and increasing treatment costs could create pressure from policymakers, insurers and patients. Greater regulation may address some affordability concerns, but excessive price controls could also reduce the flow of private capital needed to expand healthcare infrastructure.

The key challenge for India's healthcare industry is therefore no longer simply building more hospitals. It is creating a system in which hospitals can attract investment and deliver advanced care while insurance remains affordable and patients are protected from unsustainable out-of-pocket costs.